Company intelligence / Profile preview

BioTrace Technologies

San Jose, California, United Statesgiiresearch.com ↗

Ownership: Private
Development stage: Commercial

Overview

BioTrace Medical developed the Tempo Lead, an FDA-cleared temporary cardiac pacing lead designed to minimize complications and allow earlier patient ambulation after procedures such as TAVR. The technology has been well received by clinicians and aims to set new standards for safety and efficacy in temporary pacemaker support[2].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships identified.

Beyond the preview

Go deeper on BioTrace Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioTrace Technologies.

Explore the full profile